Anticoagulant Treatments Evaluation During Percutaneous Coronary Angioplasty in Stable Patients (TACA)

NCT00669149 Phase 4 TERMINATED

The purpose of this study is to determine whether adjunction of intravenous anticoagulant therapy (enoxaparin, HNF, bivalirudin) to antiaggregation with clopidogrel and aspirin improves in-hospital results of percutaneous transluminal coronary angioplasty (ptca) in selected patients.

Details

Lead sponsor	Centre Hospitalier de PAU
Phase	Phase 4
Status	TERMINATED
Enrolment	99
Start date	2008-06
Completion	2013-08-03

Conditions

• Coronary Artery Disease

Interventions

• clopidogrel + aspirin
• heparin + clopidogrel + aspirin
• enoxaparin + clopidogrel + aspirin
• bivalirudin + clopidogrel + aspirin

Primary outcomes

• ischaemic events via troponin Ic measurements during 24 hours post procedure — 24 hours

Countries

France